Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Luxa Biotechnology, Llc

Clinical trials sponsored by Luxa Biotechnology, Llc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Can stem cells save sight? new trial tests eye cell transplant for dry AMD Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Can stem cells save sight? new trial tests eye cell transplant for dry AMD

Disease control Recruiting now

This early-stage trial tests whether transplanting lab-grown retinal cells (RPESC-RPE-4W) into the eye is safe for people with dry age-related macular degeneration (AMD), a leading cause of vision loss. About 18 adults over 55 will receive the transplant and be monitored for side…

Phase 1/2 • Sponsor: Luxa Biotechnology, LLC • Aim: Disease control

Last updated Jun 27, 2026 07:54 UTC